硫酸化
葡萄糖醛酸化
化学
轨道轨道
生物化学
新陈代谢
类黄酮
抗氧化剂
质谱法
色谱法
体外
微粒体
作者
Wenwen Zhang,Dongyuan Liu,Enning Zhou,Weiwei Wang,Hao Wang,Qiangqiang Li
标识
DOI:10.1016/j.jff.2023.105675
摘要
Tiliroside, as a dietary flavonoid, has great potential in preventing or treating non-alcoholic fatty liver disease (NAFLD). However, research on tiliroside metabolism remains unclear, limiting its further utilization in healthcare. Herein, we explored the hepatoprotective effect of tiliroside and performed an UHPLC-Q-Exactive Orbitrap/MS-based set of experiments to identify metabolites and metabolic pathways of tiliroside in human hepatocytes. Results showed that tiliroside can exert antioxidant activity to protect against palmitic acid (PA)-induced oxidative injury in hepatocytes. Moreover, tiliroside was found to be considerably transformed through metabolism in human hepatocytes based on full MS and MS/MS analysis. Fifteen metabolites derived from the glucuronidation, sulfation, hydrolysis, and oxidation of tiliroside were identified. Glucuronidation and sulfation played key roles in tiliroside metabolism, accounting for approximately 32% and 20% of metabolism after 240 min incubation, respectively. The findings could provide a scientific basis for a more rational and effective application of tiliroside in healthcare.
科研通智能强力驱动
Strongly Powered by AbleSci AI